Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-048746

President and CEO sold 34,196 shares at an average $21.09 ($721,236)

  • President and CEO acquired 34,196 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fordyce Marshall President and CEO 2022-09-01 Option exercise +17,100 $2.90 $49,535 198,250 D: show line 1 in the form
Fordyce Marshall President and CEO 2022-09-01 Sale −17,100 $21.22 $362,783 181,150 D: show line 2 in the form
Fordyce Marshall President and CEO 2022-09-02 Option exercise +7,346 $2.90 $21,280 188,496 D: show line 3 in the form
Fordyce Marshall President and CEO 2022-09-02 Sale −7,346 $20.26 $148,863 181,150 D: show line 4 in the form
Fordyce Marshall President and CEO 2022-09-02 Option exercise +9,750 $2.90 $28,244 190,900 D: show line 5 in the form
Fordyce Marshall President and CEO 2022-09-02 Sale −9,750 $21.50 $209,590 181,150 D: show line 6 in the form
Open-market sales · 34,196 sh · avg $21.09 · $721,236

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fordyce Marshall President and CEO 2022-09-01 Option exercise · Stock Option (right to buy) −17,100 1,073,012 D: show line 7 in the form
Fordyce Marshall President and CEO 2022-09-02 Option exercise · Stock Option (Right to Buy) −17,096 1,055,916 D: show line 8 in the form
Loading xslF345X03/doc4.xml…